- Home
- KNX vs ROIV Comparison
KNX vs ROIV Comparison
Compare KNX & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNX
- ROIV
- Stock Information
- Founded
- KNX 1989
- ROIV 2014
- Country
- KNX United States
- ROIV United Kingdom
- Employees
- KNX N/A
- ROIV N/A
- Industry
- KNX Trucking Freight/Courier Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- KNX Industrials
- ROIV Health Care
- Exchange
- KNX Nasdaq
- ROIV Nasdaq
- Market Cap
- KNX 7.2B
- ROIV 8.4B
- IPO Year
- KNX 1994
- ROIV N/A
- Fundamental
- Price
- KNX $45.56
- ROIV $10.79
- Analyst Decision
- KNX Buy
- ROIV Buy
- Analyst Count
- KNX 16
- ROIV 4
- Target Price
- KNX $51.60
- ROIV $17.50
- AVG Volume (30 Days)
- KNX 3.2M
- ROIV 5.9M
- Earning Date
- KNX 04-23-2025
- ROIV 05-29-2025
- Dividend Yield
- KNX 1.58%
- ROIV N/A
- EPS Growth
- KNX 37.21
- ROIV N/A
- EPS
- KNX 0.93
- ROIV N/A
- Revenue
- KNX $7,411,973,000.00
- ROIV $122,585,000.00
- Revenue This Year
- KNX $3.01
- ROIV N/A
- Revenue Next Year
- KNX $6.69
- ROIV N/A
- P/E Ratio
- KNX $48.96
- ROIV N/A
- Revenue Growth
- KNX 1.16
- ROIV 140.04
- 52 Week Low
- KNX $36.69
- ROIV $8.73
- 52 Week High
- KNX $61.51
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- KNX 61.27
- ROIV 50.06
- Support Level
- KNX $45.13
- ROIV $10.58
- Resistance Level
- KNX $49.39
- ROIV $11.77
- Average True Range (ATR)
- KNX 1.36
- ROIV 0.34
- MACD
- KNX 0.90
- ROIV -0.07
- Stochastic Oscillator
- KNX 67.07
- ROIV 17.65
About KNX Knight-Swift Transportation Holdings Inc.
Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the U.S. Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.